8-OH-DPAT as a 5-HT7 agonist: phase shifts of the circadian biological clock through increases in cAMP production.
about
Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disordersSignal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonistWhat Do We Really Know About 5-HT1A Receptor Signaling in Neuronal Cells?Targeting the Serotonin 5-HT7 Receptor in the Search for Treatments for CNS Disorders: Rationale and Progress to DateSystematic identification of proteins that elicit drug side effectsConservation of structure, signaling and pharmacology between two serotonin receptor subtypes from decapod crustaceans, Panulirus interruptus and Procambarus clarkiiChronic reductions in serotonin transporter function prevent 5-HT1B-induced behavioral effects in mice.The 5-HT7 receptor and disorders of the nervous system: an overview.Distinct temporal expression of 5-HT(1A) and 5-HT(2A) receptors on cerebellar granule cells in miceRole of the 5-HT7 receptor in the central nervous system: from current status to future perspectives.Autoradiographic evaluation of [3H]CUMI-101, a novel, selective 5-HT1AR ligand in human and baboon brain.Correction of respiratory disorders in a mouse model of Rett syndrome.Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 2, pharmacological interactions in rodents suggest a role of serotonin-3 receptor antagonism.Genome-wide association study of theta band event-related oscillations identifies serotonin receptor gene HTR7 influencing risk of alcohol dependence.Pharmacological modulation of circadian rhythms: a new drug target in psychotherapeutics.Serotonin and blood pressure regulation.Acute ethanol modulates glutamatergic and serotonergic phase shifts of the mouse circadian clock in vitro.Anxiolytics may promote locomotor function recovery in spinal cord injury patients.Selective serotonin 5-HT1A receptor biased agonists elicitdistinct brain activation patterns: a pharmacoMRI studyExpression and function of 5-HT7 receptors in smooth muscle preparations from equine duodenum, ileum, and pelvic flexure.Hippocampal serotonin-1A receptor function in a mouse model of anxiety induced by long-term voluntary wheel running.5-HT(7) receptor modulators: a medicinal chemistry survey of recent patent literature (2004 - 2009).Serotonin and sensory nerves: meeting in the cardiovascular system.The 5-HT7 receptor as a potential target for treating drug and alcohol abuse.Clozapine effects on adenylyl cyclase activity and serotonin type 1A receptors in human brain post-mortem.Serotonin 1A receptor inhibits the status epilepticus induced by lithium-pilocarpine in rats.Selective pharmacological blockade of the 5-HT7 receptor attenuates light and 8-OH-DPAT induced phase shifts of mouse circadian wheel running activity.Mice lacking 5-HT receptors show specific impairments in contextual learning.Effect of haloperidol on mPer1 gene expression in mouse suprachiasmatic nuclei.Central 5-HT7 receptors are critical for reflex activation of cardiac vagal drive in anaesthetized rats.Neuronal control of pedal sole cilia in the pond snail Lymnaea stagnalis appressa.Circadian rhythm phenotype of 5-HT7 receptor knockout mice: 5-HT and 8-OH-DPAT-induced phase advances of SCN neuronal firing.Electroacupuncture alleviates chemotherapy-induced pain through inhibiting phosphorylation of spinal CaMKII in rats.Role of 5-HT1A receptor stimulation in the medial prefrontal cortex in the sustained antidepressant effects of ketamine.Persistent modification of forebrain networks and metabolism in rats following adolescent exposure to a 5-HT7 receptor agonist.Serotonergic mediation of constant light-potentiated nonphotic phase shifting of the circadian locomotor activity rhythm in Syrian hamsters.Synthesis and Structure-Activity Relationship Analysis of 5-HT₇ Receptor Antagonists: Piperazin-1-yl Substituted Unfused Heterobiaryls.Photic and nonphotic responses of the circadian clock in serotonin-deficient Pet-1 knockout mice.Activation of the external urethral sphincter central pattern generator by a 5-HT(1A) receptor agonist in rats with chronic spinal cord injury.Synthesis and configuration determination of all enantiopure stereoisomers of the melatonin receptor ligand 4-phenyl-2-propionamidotetralin using an expedient optical resolution of 4-phenyl-2-tetralone.
P2860
Q24632508-A6AE2FB0-B830-4B96-9B8A-752320249C70Q24644854-FA08568E-3BC0-4CD8-B931-8C5BDDB2A135Q28067492-2C92DFE8-F945-46B7-B582-06ABC33A2E31Q28084125-45C64D43-2596-458F-84E0-B285861224A9Q30002377-5B8E3A78-AFA1-4CE8-B667-BE56E6C43596Q30366561-6F700D28-0441-4402-AF8F-404B097C963EQ30482896-84CC0E33-8C4E-4AE2-B0FB-F77A8323DC36Q33738349-848AA182-BDC9-43E0-BCE7-EA0FF4659BA6Q33829295-BCE3776F-3C33-405E-A3AE-7EEDE2A5BC63Q34172419-E0999A52-EE43-4D00-99D4-B9749C9A3C7FQ34214169-12069CBB-179C-4888-B824-95E6C670B2DCQ34241587-6D7E5217-B6F6-4A8C-9A30-616884C32887Q34671692-D2FBF8BA-CF81-4CFA-8FA1-96EBED80700AQ35116111-EB39130B-8B1E-448E-A57E-E36CEFBCC8CAQ35680557-32EAF969-0CD5-4DB3-A7B5-372E05984429Q35847080-53B0B797-5347-4AE7-BE0E-3288DA7C6098Q36648594-5E28CA3C-C8C1-45CA-9DD5-26ED0C260360Q36876442-2DA5D03D-6FD7-4C52-ABF8-C3E3D67AA993Q36925361-350D0FD8-71EE-4B07-B5DD-2283AE482205Q37268779-4452374B-D5A3-4C89-9558-B601A325CA2EQ37276931-5021CA03-70B9-40E3-9CBE-8417B6753B48Q37754465-86EF1CC7-30A9-4C05-8165-ED76C5FA6E74Q38245521-56056980-8F2A-43CC-B009-439BCE86CB62Q38335136-5764157E-C904-4274-A15C-6D870AAD4445Q39271592-5DF4B41B-7FE2-415A-B4F9-5D77AD6A0C46Q41458065-BD472A76-9D82-491A-BE0E-E5C9A4FA3853Q41841409-814E105C-7C51-4D57-A68A-5F3E2C28A9C3Q44840065-8A2E4041-FAA6-41BB-9312-64E45D9093C3Q45182269-A47F7155-F479-4D49-BEE4-2F34E4BD4502Q45195693-E6084247-DE9C-40FE-94EA-6ED9A44C68DBQ45797696-D5199A48-E174-480A-A580-BA5F3BC0E5B1Q46440467-7F8CCF8F-D061-4411-B22A-880BB85BE145Q47649743-3842C4DC-131E-4786-A0B8-777E5BA53F4CQ47662037-6571753C-EDAB-4D05-97BC-5E0E6640FAF1Q48100455-58711F55-AB28-49B6-A687-163997E29605Q48497966-166F26FC-C348-472D-8144-AFC31942C964Q48562904-F9060CC7-CFE3-4A1F-A9AB-F2D716E0B271Q50720134-1751CA4F-D90B-4C07-9F90-775FF3018089Q51771605-0AEC692C-FB42-4334-95BB-6DD4C4D129D2Q53204974-E0396126-57F8-4D77-9E36-6AE70FCF8859
P2860
8-OH-DPAT as a 5-HT7 agonist: phase shifts of the circadian biological clock through increases in cAMP production.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
8-OH-DPAT as a 5-HT7 agonist: ...... increases in cAMP production.
@ast
8-OH-DPAT as a 5-HT7 agonist: ...... increases in cAMP production.
@en
8-OH-DPAT as a 5-HT7 agonist: ...... increases in cAMP production.
@nl
type
label
8-OH-DPAT as a 5-HT7 agonist: ...... increases in cAMP production.
@ast
8-OH-DPAT as a 5-HT7 agonist: ...... increases in cAMP production.
@en
8-OH-DPAT as a 5-HT7 agonist: ...... increases in cAMP production.
@nl
prefLabel
8-OH-DPAT as a 5-HT7 agonist: ...... increases in cAMP production.
@ast
8-OH-DPAT as a 5-HT7 agonist: ...... increases in cAMP production.
@en
8-OH-DPAT as a 5-HT7 agonist: ...... increases in cAMP production.
@nl
P2093
P1433
P1476
8-OH-DPAT as a 5-HT7 agonist: ...... increases in cAMP production.
@en
P2093
Anne Schmidt
John Braselton
Linda Reynolds
Xingfang Li
P356
10.1016/J.NEUROPHARM.2003.08.007
P577
2004-01-01T00:00:00Z